66 related articles for article (PubMed ID: 2744630)
21. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
[TBL] [Abstract][Full Text] [Related]
22. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
23. Comparison of a recombinant thromboplastin with Thrombotest for oral anticoagulant control.
Baele G; Fiers T; Leroux-Roels G
Haemostasis; 1996; 26(1):11-5. PubMed ID: 8698273
[TBL] [Abstract][Full Text] [Related]
24. Relationship between elevated fibrinopeptide A levels and alpha-2-antiplasmin.
Marongiu F; Mulas G; Mamusa AM; Mameli G; Marassi PP; Tronci MB; Cambuli AB; Acca MR; Balestrieri AA
Haemostasis; 1987; 17(5):301-4. PubMed ID: 3666588
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of septic pelvic thrombophlebitis by measurement of fibrinopeptide A.
Weiner CP; Kwaan H; Duboe F
Am J Perinatol; 1985 Apr; 2(2):93-5. PubMed ID: 4096764
[TBL] [Abstract][Full Text] [Related]
26. Evidence for a relationship between high fibrinogen levels and decreased thrombin activity in vivo in elderly subjects.
Marongiu F; Mamusa AM; Dessalvi P; Mameli G; Cambuli AB; Sorano GG; Conti M; Farci P; Balestrieri A
Haemostasis; 1989; 19(2):91-3. PubMed ID: 2731780
[TBL] [Abstract][Full Text] [Related]
27. The relationship between Normotest and Thrombotest in patients on oral anticoagulant therapy.
Refsum N; Arnesen H; Gilhuus-Moe CC; Godal HC
Scand J Haematol; 1977 Apr; 18(4):333-6. PubMed ID: 854707
[TBL] [Abstract][Full Text] [Related]
28. Thrombin induces broad spectrum proteolysis in human serum samples.
O'Mullan P; Craft D; Yi J; Gelfand CA
Clin Chem Lab Med; 2009; 47(6):685-93. PubMed ID: 19099528
[TBL] [Abstract][Full Text] [Related]
29. Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment?
Wolters HJ; ten Cate H; Thomas LL; Brandjes DP; van der Ende A; van der Heiden Y; Statius van Eps LW
Br J Haematol; 1995 Jul; 90(3):715-7. PubMed ID: 7647016
[TBL] [Abstract][Full Text] [Related]
30. Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effect on coagulation factor testing.
Walenga JM; Drenth AF; Mayuga M; Hoppensteadt DA; Prechel M; Harder S; Watanabe H; Osakabe M; Breddin HK
Clin Appl Thromb Hemost; 2008 Jul; 14(3):325-31. PubMed ID: 18586683
[TBL] [Abstract][Full Text] [Related]
31. Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.
Profumo A; Turci M; Damonte G; Ferri F; Magatti D; Cardinali B; Cuniberti C; Rocco M
Biochemistry; 2003 Oct; 42(42):12335-48. PubMed ID: 14567695
[TBL] [Abstract][Full Text] [Related]
32. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
Cronlund M; Hardin J; Burton J; Lee L; Haber E; Bloch KJ
J Clin Invest; 1976 Jul; 58(1):142-51. PubMed ID: 932202
[TBL] [Abstract][Full Text] [Related]
33. Endogenous thrombin potential in Behçet's disease: relationship with thrombosis and anticoagulant therapy.
Mejía JC; Espinosa G; Tàssies D; Reverter JC; Cervera R
Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S67-71. PubMed ID: 25068444
[TBL] [Abstract][Full Text] [Related]
34. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty.
Vaitkus PT; Watkins MW; Witmer WT; Tracy RP; Sobel BE
Coron Artery Dis; 1995 Jul; 6(7):587-92. PubMed ID: 7582198
[TBL] [Abstract][Full Text] [Related]
35. Thrombin activity and oral anticoagulant therapy: a further evaluation.
Marongiu F; Sorano GG; Mameli G; Mamusa AM; Cambuli AB; Conti M; Cadoni MC; Balestrieri A
Haemostasis; 1990; 20(1):63-4. PubMed ID: 2323681
[No Abstract] [Full Text] [Related]
36. The effect of exercise on thrombin and plasmin generation in middle-aged men.
Small M; Simpson I; McGhie I; Douglas JT; Lowe GD; Forbes CD
Haemostasis; 1987; 17(6):371-6. PubMed ID: 2962911
[TBL] [Abstract][Full Text] [Related]
37. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
van Leeuwen Y; Rosendaal FR; van der Meer FJ
Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
[TBL] [Abstract][Full Text] [Related]
38. Effects of intermittent pneumatic calf compression on postoperative thrombin and plasmin activity.
Weitz J; Michelsen J; Gold K; Owen J; Carpenter D
Thromb Haemost; 1986 Oct; 56(2):198-201. PubMed ID: 2949390
[TBL] [Abstract][Full Text] [Related]
39. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity.
Ni F; Zhu Y; Scheraga HA
J Mol Biol; 1995 Oct; 252(5):656-71. PubMed ID: 7563081
[TBL] [Abstract][Full Text] [Related]
40. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]